During the past decade, Radiant Research conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 39 clinical trials were completed, i.e. on average, 86.7% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 25 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Radiant Research" #1 sponsor was "Abbott Nutrition" with 12 trials, followed by "Eli Lilly and Company" with 11 trials sponsored, "Pfizer" with 7 trials sponsored, "Allergan" with 5 trials sponsored and "GlaxoSmithKline" with 5 trials sponsored. Other sponsors include 57 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Radiant Research" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "Benu BioPharma, LLC" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "McNeil AB" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Radiant Research" are "Psoriasis" (10 trials), "Diabetes" (6 trials), "Diabetes Mellitus" (4 trials), "Diabetes Mellitus, Type 2" (4 trials) and "Diabetic Peripheral Neuropathic Pain" (4 trials). Many other conditions were trialed in "Radiant Research" in a lesser frequency.

Most popular intervention types in "Radiant Research" are "Drug" (66 trials), "Other" (16 trials), "Biological" (12 trials), "Device" (7 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "LY3016859" (3 trials), "LY3556050" (3 trials), "Relamorelin" (3 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

The vast majority of trials in "Radiant Research" are 92 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Radiant Research". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 84 completed trials in Radiant Research, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Radiant Research, 1 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 13 trials that are defined as “Not Applicable".